Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

Nature Medicine

Volumn 7, Issue 3, 2001, Pages 369-372

  Bacskai, Brian J ^a   Kajdasz, Stephen T ^a   Christie, Richard H ^a   Carter, Cordelia ^a   Games, Dora ^b   Seubert, Peter ^b   Schenk, Dale ^b   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ELAN PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; IMAGE ANALYSIS; IMAGING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; BRAIN; IMMUNOTHERAPY; MICE; MICROGLIA; MICROSCOPY, FLUORESCENCE;

ANIMALIA;

EID: 0035106780     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/85525     Document Type: Article

References (14)

1. Neuropathological stageing of Alzheimer-related changes
2. Profound ross of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
3. Alzheimer neuropathologic alterations in aged cognitively normal subjects
4. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
5. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
6. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
7. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
8. Two-photon laser scanning fluorescence microscopy
9. In vivo dendritic calcium dynamics in neocortical pyramidal neurons
10. Dynamic mapping at the laminar revel of odor-elicited responses in rat olfactory bulb by functional MRI
11. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease
12. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease
13. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
14. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide